Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Operating Income: 2015-2024

Historic Operating Income for Insight Molecular Diagnostics (IMDX) over the last 10 years, with Dec 2024 value amounting to -$61.0 million.

  • Insight Molecular Diagnostics' Operating Income rose 18.25% to -$11.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$61.3 million, marking a year-over-year decrease of 40.66%. This contributed to the annual value of -$61.0 million for FY2024, which is 142.84% down from last year.
  • As of FY2024, Insight Molecular Diagnostics' Operating Income stood at -$61.0 million, which was down 142.84% from -$25.1 million recorded in FY2023.
  • Insight Molecular Diagnostics' 5-year Operating Income high stood at -$18.0 million for FY2022, and its period low was -$61.0 million during FY2024.
  • Over the past 3 years, Insight Molecular Diagnostics' median Operating Income value was -$25.1 million (recorded in 2023), while the average stood at -$34.7 million.
  • As far as peak fluctuations go, Insight Molecular Diagnostics' Operating Income spiked by 66.50% in 2022, and later tumbled by 142.84% in 2024.
  • Insight Molecular Diagnostics' Operating Income (Yearly) stood at -$29.7 million in 2020, then plummeted by 80.83% to -$53.7 million in 2021, then soared by 66.50% to -$18.0 million in 2022, then plummeted by 39.67% to -$25.1 million in 2023, then slumped by 142.84% to -$61.0 million in 2024.